ScholarRx Revenue and Competitors

Location

N/A

Total Funding

Education

Industry

Estimated Revenue & Valuation

  • ScholarRx's estimated annual revenue is currently $19.1M per year.(i)
  • ScholarRx's estimated revenue per employee is $180,000

Employee Data

  • ScholarRx has 106 Employees.(i)
  • ScholarRx grew their employee count by 13% last year.

ScholarRx's People

NameTitleEmail/Phone
1
VP, Academic SolutionsReveal Email/Phone
2
Director Quality & DeliveryReveal Email/Phone
3
Senior Director Academic SolutionsReveal Email/Phone
4
Chief Technology OfficerReveal Email/Phone
5
Director, Academic SolutionsReveal Email/Phone
6
Director Basic Science EducationReveal Email/Phone
7
Director Editorial and Program ManagementReveal Email/Phone
8
Senior Director ProductReveal Email/Phone
9
Director Content ProductionReveal Email/Phone
10
Digital Marketing ManagerReveal Email/Phone
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$19.1M10613%N/AN/A
#2
$18.7M1046%N/AN/A
#3
$13.7M7631%N/AN/A
#4
$36.4M1848%N/AN/A
#5
$22.1M12317%N/AN/A
#6
$218.2M866N/AN/AN/A
#7
$296.4M1176N/AN/AN/A
#8
$17.5M9729%N/AN/A
#9
$9.9M619%N/AN/A
#10
$106.4M473N/AN/AN/A
Add Company

What Is ScholarRx?

ScholarRx is a leading provider of accessible, sustainable medical education solutions for medical schools worldwide. Our new Rx Bricks initiative features collections of interlocking foundational-learning “bricks” that empower faculty to rapidly design and develop engaging, evidence-based curricular experiences. Our USMLE-Rx assessment platform combines authentic USMLE-style Q&A, digital flashcards, and high-yield video all powered by First Aid for the USMLE Step 1 with robust performance reporting to create personalized active-learning experiences with measurable outcomes.

keywords:N/A

N/A

Total Funding

106

Number of Employees

$19.1M

Revenue (est)

13%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$7.5M10620%N/A
#2
$28.6M106-31%N/A
#3
$3.5M10680%N/A
#4
$28.6M10620%N/A
#5
$22.3M10661%N/A